Eagle Bay Advisors LLC
- SEC CIK
- 0001862864
- Latest filing
- Aug 3, 2026
NVS holding history
Novartis AG in every 13F filed by Eagle Bay Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −184−100.0% | Sold out | Holders |
| Q4 2024 | 184 | $17.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 184 | $21.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 184 | $19.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 184 | $18.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 184 | $18.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 184 | $18.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 184 | $18.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 184 | $16.9K | <0.1% | +48+35.3% | Added | Holders |
| Q4 2022 | 136 | $12.3K | <0.1% | −800−85.5% | Reduced | Holders |
| Q3 2022 | 936 | $71.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 936 | $79.1K | <0.1% | +936 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −1,209−100.0% | Sold out | Holders |
| Q4 2021 | 1,209 | $106.0K | 0.1% | −1,038−46.2% | Reduced | Holders |
| Q3 2021 | 2,247 | $183.0K | 0.1% | +1,037+85.7% | Added | Holders |
| Q2 2021 | 1,210 | $115.0K | 0.1% | – | No prior filing | Holders |